Risk factors

ARKO Corp. relies heavily on tobacco sales and motor fuel distribution for its revenues and operational margins.

International sales grew to 22.2% of total sales in 2024, exposing the company to greater foreign currency, regulatory, and operational risks.

Alphatec Holdings faces intense competition in the spine surgery market from large established device makers. The company relies heavily on systems featuring polyaxial pedicle screws and a single supplier, Invibio, for PEEK raw materials. Financial performance is constrained by a history of net losses and a $1.3 billion accumulated deficit.

Regulatory rate recovery lag and operating cost growth dominate Avista's operational risks.

International operations generate seventy percent of sales, exposing the company to currency fluctuations, geopolitical instability, and regulatory changes. Raw material volatility and labor costs directly impact manufacturing profitability and capital allocation strategies.

Axogen relies heavily on Avance Nerve Graft, representing 60% of total revenue and awaiting FDA BLA approval.

Axis Capital faces significant cyclical pricing pressures, natural catastrophe exposures, and complex evolving regulatory requirements across multiple global jurisdictions.

Banner Corp faces concentrated risks from regional economic conditions, commercial and residential real estate lending exposure, interest rate fluctuations, and evolving regulatory standards such as FDIC corporate governance and DEI compliance.

Bone Biologics faces severe going concern doubts, relying on $4.1M cash to fund operations through late 2025.

Geographic concentration in California, Texas, and Florida creates high sensitivity to local economic and regulatory shifts. Rising labor, commodity, and food costs threaten profit margins if menu prices cannot offset them. Third-party delivery commissions and strict alcohol licensing rules heavily impact operating results.

Bloomin' Brands faces major risks from food safety incidents, intense restaurant competition, labor shortages, and high debt levels.

International infrastructure software sales drive our revenue, exposing us to foreign currency, APAC market trends, and long project timelines.